292 related articles for article (PubMed ID: 10729656)
1. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Bhavnani SM; Drake JA; Forrest A; Deinhart JA; Jones RN; Biedenbach DJ; Ballow CH
Diagn Microbiol Infect Dis; 2000 Mar; 36(3):145-58. PubMed ID: 10729656
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Lucas GM; Lechtzin N; Puryear DW; Yau LL; Flexner CW; Moore RD
Clin Infect Dis; 1998 May; 26(5):1127-33. PubMed ID: 9597241
[TBL] [Abstract][Full Text] [Related]
3. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
Vergis EN; Hayden MK; Chow JW; Snydman DR; Zervos MJ; Linden PK; Wagener MM; Schmitt B; Muder RR
Ann Intern Med; 2001 Oct; 135(7):484-92. PubMed ID: 11578151
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.
Kohler P; Eshaghi A; Kim HC; Plevneshi A; Green K; Willey BM; McGeer A; Patel SN;
PLoS One; 2018; 13(3):e0193926. PubMed ID: 29566004
[TBL] [Abstract][Full Text] [Related]
6. The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
Jiang HL; Zhou Z; Wang LS; Fang Y; Li YH; Chu CI
Int J Infect Dis; 2017 Jan; 54():18-24. PubMed ID: 27836794
[TBL] [Abstract][Full Text] [Related]
7. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant enterococcus in end-stage renal disease.
Brady JP; Snyder JW; Hasbargen JA
Am J Kidney Dis; 1998 Sep; 32(3):415-8. PubMed ID: 9740157
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
[TBL] [Abstract][Full Text] [Related]
10. Enterococcus faecium bacteremia: does vancomycin resistance make a difference?
Stosor V; Peterson LR; Postelnick M; Noskin GA
Arch Intern Med; 1998 Mar; 158(5):522-7. PubMed ID: 9508230
[TBL] [Abstract][Full Text] [Related]
11. Impact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.
Cho SY; Lee DG; Choi SM; Kwon JC; Kim SH; Choi JK; Park SH; Park YJ; Choi JH; Yoo JH
BMC Infect Dis; 2013 Oct; 13():504. PubMed ID: 24164924
[TBL] [Abstract][Full Text] [Related]
12. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
13. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
[TBL] [Abstract][Full Text] [Related]
14. [Vancomycin resistant enterococci in Austria].
Allerberger F; Lass-Flörl C; Dierich MP; Hirschl AM; Presterl E; Haas G; Klare I; Witte W
Wien Klin Wochenschr; 1997 May; 109(9):312-20. PubMed ID: 9265389
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
[TBL] [Abstract][Full Text] [Related]
16. Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.
Peel T; Cheng AC; Spelman T; Huysmans M; Spelman D
Clin Microbiol Infect; 2012 Apr; 18(4):388-94. PubMed ID: 21848977
[TBL] [Abstract][Full Text] [Related]
17. VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis.
Prematunge C; MacDougall C; Johnstone J; Adomako K; Lam F; Robertson J; Garber G
Infect Control Hosp Epidemiol; 2016 Jan; 37(1):26-35. PubMed ID: 26434609
[TBL] [Abstract][Full Text] [Related]
18. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
[TBL] [Abstract][Full Text] [Related]
19. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
20. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation.
Kapur D; Dorsky D; Feingold JM; Bona RD; Edwards RL; Aslanzadeh J; Tutschka PJ; Bilgrami S
Bone Marrow Transplant; 2000 Jan; 25(2):147-52. PubMed ID: 10673672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
